• Hisham A Badreldin and Bassam Atallah.
• Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia. Electronic address: Aldeenh@ksau-hs.edu.sa.
• Res Social Adm Pharm. 2021 Jan 1; 17 (1): 1946-1949.

AbstractCoronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.Copyright © 2020. Published by Elsevier Inc.

16 keywords...

hide…